Transcept Pharmaceuticals to Hold Conference Call on Agreement with Purdue Pharmaceutical Products L.P. to Commercialize Intermezzo(R) in the United States
PT. RICHMOND, Calif., Aug. 2 /PRNewswire-FirstCall/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT ) will host a conference call to discuss its exclusive license and collaboration agreement with Purdue Pharmaceutical Products L.P. to commercialize
Intermezzo ((R)) (zolpidem t...
Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products
Multi-Product Collaboration Valued Potentially at More Than $500 Million
COLLEGEVILLE, Pa., and SOUTH SAN FRANCISCO, Calif., June 30 /PRNewswire/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE ) and Catalyst Biosciences, Inc. today announced that the two companies have formed an e...
moksha8 Expands Alliance With Roche to Commercialize $200 Million of Products in Brazil and Mexico
MEXICO CITY, SAO PAULO and PHILADELPHIA, May 20 /PRNewswire/ -- moksha8, Inc. announced today that it has expanded its strategic partnership with Roche to commercialize
an additional portfolio of products in Mexico currently generating sales of $140 million USD.
moksha8 will commercialize
BD and HandyLab Announce Exclusive Collaboration to Commercialize Molecular Assays
Fully Automated, Integrated BD MAX(TM) System for Rapid Testing for Infectious Diseases Incorporates the New HandyLab Automated PCR System
FRANKLIN LAKES, N.J. and ANN ARBOR, Mich., May 18 /PRNewswire-FirstCall/ -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX )...
Rubicon Genomics Announces a Licensing Agreement With Abbott to Develop and Commercialize DNA Methylation Cancer Tests
ANN ARBOR, Mich., Jan. 12 /PRNewswire/ -- Rubicon Genomics today announced a licensing agreement with Abbott, which marks the achievement of significant milestones within their on-going Research and Option Agreement for development and commercialization of Rubicon MethylPlex(TM) methylation detect...
Toyota Tsusho America, Inc. and Nippon Kayaku Co., Ltd. Announce the Formation of GlycoMark, Inc., a Joint Venture to Develop and Commercialize Novel Biomarkers for Diabetes
GlycoMark(R) Blood Test Now Established to Provide Physicians with Vital Information Missed by Hemoglobin A1c Test to More Effectively Manage Patients with Diabetes
NEW YORK and WINSTON-SALEM, N.C., July 17 /PRNewswire/ -- Toyota Tsusho
America, Inc. (New York, NY) and...
Response Biomedical Corporation Announces Strategic Partnership with Roche Diagnostics To Commercialize Cardiovascular Tests
VANCOUVER, June 26 /PRNewswire-FirstCall/ - Response Biomedical
Corporation (TSX: RBM, OTCBB: RPBIF) announced today that it has entered
into an agreement granting rights to Roche Diagnostics to market its line
of cardiovascular point-of-care (POC) tests worldwide. Roche Diagnostics'
Allegro Diagnostics Closes $4 Million Round to Develop and Commercialize Lung Cancer Molecular Diagnostics Based on Gene Expression
Jerome Brody, MD Joins Company as Chief Scientific Officer
BOSTON, March 7 /PRNewswire/ -- Allegro Diagnostics, a leader in the
field of molecular diagnostics for lung cancer, has announced completion of
$4 million in Series A financing. Kodiak Venture Partners led the round and
UCLA-industry partnership to develop, commercialize new nanotechnology
The California NanoSystems Institute (CNSI) at UCLA and NanoPacific Holdings Inc. have announced a partnership to commercialize
a mechanized, nanoparticle-based technology that could lead to prolonged lives of enhanced quality for millions of cancer sufferers.
Under the terms of the partners...
King Pharmaceuticals and Acura Pharmaceuticals Enter Agreement to Develop and Commercialize Immediate Release Pain Medicines Utilizing Acura's Aversion(R) (Abuse-Deterrent) Technology
Transaction Expands King's Near-term Pipeline of Products Designed to Deter Common Methods of Opioid Abuse
BRISTOL, Tenn. and PALATINE, Ill., Oct. 31 /PRNewswire-FirstCall/ --
King Pharmaceuticals, Inc. (NYSE: KG ) and Acura Pharmaceuticals, Inc. (OTC
Bulletin Board: ACUR) a...
commercialize in Medical Technology
Tibotec Pharmaceuticals Announces Agreement to Develop and Commercialize a New Fixed-Dose Combination of TMC278 and Truvada(R) With Gilead Sciences
CORK, Ireland, July 16 /PRNewswire/ --Tibotec Pharmaceuticals today announced that it has entered into a license and collaboration agreement with Gilead Sciences, Inc. for the development and commercialization of a new once-daily fixed-dose antiretroviral product containing Tibotec's inv...
Unibioscreen and Drais Pharmaceuticals Partner to Develop and Commercialize UNBS 5162 for Treatment of Cancer
BRIDGEWATER, N.J., and BRUSSELS, Belgium, Sept. 15 /PRNewswire/ --
Drais Pharmaceuticals, Inc. and Unibioscreen S.A. today announced that they
have entered into a global agreement to develop and commercialize
5162, one of Unibioscreen's investigational drug and potential breakthrough
Roche Exercises its Option to Further Develop and Commercialize Memory Pharmaceuticals' Nicotinic Alpha-7 Agonist, MEM 3454
-Memory Receives $6 Million Milestone Payment- -Memory to Host Conference Call at 9:00 a.m. EDT Today-
MONTVALE, N.J. and BASEL, Switzerland, May 2 /PRNewswire-FirstCall/ --
Memory Pharmaceuticals Corp. (Nasdaq: MEMY ) and Roche (SWX: ROG) today
announced that Roche has ex...
Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer To Develop and Commercialize RNAi Hepatitis C Drug
SAN JOSE, Calif., Jan. 7 /PRNewswire/ -- Tacere Therapeutics, Inc., an
RNA interference (RNAi)-based therapeutics developer, announced today that
it has entered into a collaboration and license agreement with Pfizer Inc.
to develop and commercialize
its Hepatitis C virus (HCV) compound, TT-033...
NewCardio Announces Master Services Agreement With Dedicated Phase I
...ellectual property, implementation of our strategic, operating and people initiatives, benefits to be derived from personnel and directors, ability to commercialize
our products, our assumptions regarding cash flow from operations and cash on-hand, the amount and timing of operating costs and capital expenditures ...
Labopharm files New Drug Submission with Health Canada for novel antidepressant
...elopment. Labopharm's vision is to become an integrated, international, specialty pharmaceutical company with the capability to internally develop and commercialize
its own products. For more information, please visit www.labopharm.com .
This press release contains forward-looking statements, which reflect t...
Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus
...any's unproven business model, its dependence on new technologies, the uncertainty and timing of clinical trials, the Company's ability to develop and commercialize
products, its dependence on collaborators for services and revenue, its substantial indebtedness and lease obligations, its changing requirements and ...
BioCryst Pharmaceuticals Reports Positive Results of Shionogi & Co. Sponsored Phase 3 Studies of i.v. Peramivir for Influenza
...usive license agreement under which Shionogi obtained rights to develop and commercialize
peramivir in Japan for the treatment of seasonal and potentially life-threa...lty payments on product sales of peramivir. BioCryst retains its rights to commercialize
peramivir in countries outside of Japan, Taiwan and South Korea.
Oncolytics Biotech(R) Inc. Announces Publication of Research on Synergistic Activity of Reovirus and Chemotherapy in NSCLC
...he efficacy of REOLYSIN as a cancer treatment, the success and timely completion of clinical studies and trials, the Company's ability to successfully commercialize
REOLYSIN, uncertainties related to the research and development of pharmaceuticals and uncertainties related to the regulatory process. Investors shou...
University of Michigan Study Shows SEQUENOM's MassARRAY Technology Identifies HPV Infections Missed by Standard Hybridization Test
...ainties that may cause actual results to differ materially, including the risks and uncertainties associated with the Company's ability to develop and commercialize
new technologies and products, particularly new technologies such as HPV DNA diagnostics and laboratory developed tests, reliance upon the collaborat...
commercialize in Medical Dictionary
...ructurally and ... The biological activity of gastrin and CCK is associated with the last five ... ... exclusive worldwide rights to develop and commercialize
Transition's gastrin ... Gastrin based therapies are an emerging class of potential disease-modifying ... Free reference information from The ...
commercialize in Biological News
CSIRO deal to commercialize 'artificial gut'
CSIRO Food Futures National Research Flagship and Australian company Stadvis Pty Ltd have signed a worldwide license agreement to commercialise an automated instrument that accurately predicts glycemic index (GI) and resistant starch (RS) in food products.
The machine will provide the food indus...
What scientists know about jewel beetle shimmer
...onics such as those envisioned for microlasers and implantable medical sensors could benefit from the finding. Scientists already are studying ways to commercialize
and apply materials that have properties similar to jewel beetles.
In one case, researchers in New Zealand are studying beetles to produce a thin, ...
Another JDRF partner moves research forward with collaboration agreement for diabetes treatment
... California, entered into a collaboration agreement with Genentech, Inc., a wholly owned member of the Roche Group, to further develop and potentially commercialize
a novel antigen-specific immunotherapeutic designed to reverse the immune response that causes type 1 diabetes.
To date, JDRF has awarded more th...
Flexible solar strips light up campus bus shelter
... has been installed to power lighting for night-time transit users.
The researchers are also hoping that the prototype will help boost efforts to commercialize
the new technology. The bus shelter is located on the west side of University Avenue between the John Hodgins Engineering Building and the Life Scien...
Blood testing, mosquito style
...ersity Technologies International, the university's technology transfer, commercialization and incubation centre that works with U of C researchers to commercialize
their technologies. "Industry has the resources and expertise to speed up the process of product development and bring this technology to market for t...
EPA's P3 award winners celebrate a green future
...ays to tackle global environmental challenges. P3 designs must be economically profitable, which is why each winner receives funding up to $75,000 to commercialize
"Scientific innovation has long been a driving force behind the U.S. economy," said Lek Kadeli, acting assistant administrator for ...
Mass Biologic Labs/UMass Med School and Medarex license C. difficile monoclonal antibody to Merck
...nfection (CDI). CDA-1 and CDB-1 were co-developed by Medarex and MBL.
Under the terms of the agreement, Merck gains worldwide rights to develop and commercialize
CDA-1 and CDB-1. Medarex and MBL will receive an upfront payment of $60 million and are potentially eligible to receive additional cash payments up t...
UniPixel Announces Availability of Opcuity(TM) Finger Print Resistant Film Test Samples
...rtner and receive samples to test for product applications.
About Uni-Pixel, Inc.
Uni-Pixel, Inc. has developed, patented, and is working to commercialize
a new color display technology it calls Time Multiplexed Optical Shutter ("TMOS"), which can be used for a wide variety of applications, ranging from ...
'Buckyballs' to treat multiple sclerosis
...been used in medicine. But the TAU and Harvard teams believe that they may resolve issues related to this nanomaterial development, and are seeking to commercialize
their patented invention. If successful, the TAU-Harvard collaboration could provide new hope to millions of MS sufferers, and would make Bucky himsel...
Troutlodge, University of Miami sign aquaculture agreement
...ly produced large numbers of cobia eggs, larvae and fingerlings. Now it is time for the private sector to take this technology to the next level and commercialize
With the agreement with Troutlodge now in place, UM's Aquaculture Program can concentrate on what it does best pioneering research on species...
commercialize in Biological Technology
Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. Sign Exclusive Agreement to Commercialize Intermezzo(R) in the United States
STAMFORD, Conn. and PT. RICHMOND, Calif., Aug. 2 /PRNewswire-FirstCall/ -- Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT ) today announced entry into an exclusive license and collaboration agreement to commercialize
Intermezzo ((R)) (z...
Amgen to Collaborate With GlaxoSmithKline to Commercialize Denosumab in Europe for Postmenopausal Osteoporosis (PMO)
THOUSAND OAKS, Calif. and LONDON, July 27 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN ) and GlaxoSmithKline (GSK) today announced a collaboration in which the companies will share commercialization of Amgen's monoclonal antibody denosumab for postmenopausal osteoporosi...
Allied Minds Establishes New Company to Commercialize Novel UC Irvine Tinnitus Therapy
BOSTON, June 11 /PRNewswire/ -- Allied Minds has established SoundCure, Inc. to improve the lives of people suffering from tinnitus (ringing in the ear). Allied Minds, a seed investment corporation specializing in early stage university business ventures, will provide the initial funding and has p...
Clarient Granted Exclusive License to Commercialize Breast Cancer Biomarker by Indiana University Research and Technology Corporation
FOXA1 biomarker predicts likelihood of recurrence and long-term disease-free survival of breast cancer patients; Further strengthens Company's breast cancer menu
ALISO VIEJO, Calif., April 23 /PRNewswire-FirstCall/ -- Clarient, Inc. , (Nasdaq: CLRT ), a premier anatomic pathology and mol...
BASF Set To Commercialize pro-t-action(TM) Eliminating Caries Causing Bacteria From the Mouth
OrganoBalance GmbH and BASF developed pro-t-action(TM) product based on probiotic microorganisms
Active ingredient easily integrated into consumer products for daily oral care
Full research studies introduced at International Association of Dental Research annual conference in Miami , ...
Human Genome Sciences and Morphotek(R), Inc. Announce Collaboration to Discover, Develop and Commercialize Antibodies for Oncology and Immunology
ROCKVILLE, Md. and EXTON, Pa., March 25 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI ) and Morphotek(R), Inc., a subsidiary of Eisai Corporation of North America, today announced that they have entered into a collaboration to discover, develop and commercialize
NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBay's Novel Aganocide Drugs for Major Dermatological Conditions
- Up to $50 Million Potential Milestones plus Double Digit Royalties on Future Sales -
- Company to Host Conference Call at 11:00 a.m. ET Today -
EMERYVILLE, Calif., March 25 /PRNewswire-FirstCall/ -- NovaBay Pharmaceuticals, Inc. (NYSE Amex: NBY ), a mid-stage biopharmaceutical comp...
PharmAthene Signs Agreement with Medison Pharma Ltd. to Commercialize and Distribute Biodefense Medical Countermeasures in Israel
ANNAPOLIS, Md., Nov. 19 /PRNewswire-FirstCall/ -- PharmAthene, Inc.
(NYSE Alternext US: PIP), a biodefense company developing medical
countermeasures against biological and chemical threats, announced today that
it has signed an agreement with Medison Pharma Ltd., to commercialize
ArunA Biomedical Announces Exclusive Worldwide Technology Licensing Agreement to Commercialize Human Embryonic Stem Cell Derived Mesenchymal Cells
ATHENS, Georgia, Aug. 19 /PRNewswire/ -- ArunA Biomedical, Inc., a
leader in human embryonic stem cell derived products, announced today that
it has entered into an exclusive worldwide technology licensing agreement
with the University of Georgia Research Foundation that will enable the
Antigen Discovery Inc. Awarded a SBIR Phase II Grant to Commercialize Novel Antigens for Serodiagnostic Products and Vaccine Development
IRVINE, Calif., July 3 /PRNewswire/ -- Antigen Discovery Inc. ("ADI",
formerly ImmPORT Therapeutics Inc.), a leader in high throughput
antigen/biomarker discovery using advanced genomics and proteomics tools,
announced today that the Company was awarded a Phase II SBIR from the
commercialize in Biological Definition
Har Gobind Khorana
...mals.Dr.khorana's invention of oligonucleotides has become indispensable tools in biotechnology. This invention of DrKhorana has become mechanized and commercialize
that anyone now can order the synthetic genes just he needs to fax the genetic sequence .